Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple Sclerosis

NCT02391961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

FED

Sponsor class

Conditions

Multiple Sclerosis
Internuclear Ophthalmoplegia
Fatigue

Interventions

DRUG: Dalfampridine
DRUG: Placebo

Sponsor

VA Office of Research and Development